NOS3 and metabolic syndrome: In animal models of metabolic syndrome, galangin improves aortic function by restoring endothelial nitric oxide synthase (eNOS) activity, enhancing nitric oxide (NO) availability, and inhibiting the angiotensin II/AT1R/TGF-β signaling axis [118].